Our investment strategy

SGT Capital generates superior returns by driving the internationalisation of mid-market businesses in combination with more traditional private equity value creation strategies.

Our investment process is characterised by a truly differentiated investment philosophy, which seeks to drive growth for Western market leaders by unlocking direct access to local as well as global markets. We will typically not invest in businesses whose products and services do not “travel” or are only locally relevant. 

We aim to invest in Western Europe, including Israel and, selectively in North America. In the European market, the Fund investments will come predominantly from Germany, Austria, Switzerland, Northern Italy, Scandinavia, and Israel. In North America, we selectively compete for mid-market businesses that benefit from an owner who can drive international expansion into Asia and/or Europe. 

We focus on sectors where their investment objective and scope are relevant. These are: 

  • Healthcare and Medical Technology, e.g., medical devices;
  • Advanced Industrials, e.g., high-end machinery/equipment, robotics, and environmental technology; and,
  • Business Services & Data and Analytics, e.g., information services and technology. 

Target companies may be acquired through a range of different transactions, including corporate carve-outs and take-private transactions (hostile acquisitions are excluded).

Post-acquisition, SGT Capital will align the assets for growth and streamline operations, thereby delivering strong returns in the targeted deal lifespan of three to five years for the investments. SGT Capital also seeks to generate superior returns by opening the Asian market to its Portfolio Companies through utilisation of strategic partnerships and strategic M&A.


SGT Capital
Genesis Building, 5th Floor, Genesis Close
PO Box 446
Cayman Islands, KY 1-1106

or by email: investor-relations@sgt-capital.com